GSK Roundup: High-Level GSK Delegation Apologizes Face-To-Face With China Ministry
This article was originally published in PharmAsia News
Executive Summary
The first face-to-face meeting of three U.K.-based GlaxoSmithKline executives with China authorities has elicited an apology from the company, according to the Public Security Ministry following the session, with Chief executive Andrew Witty set to detail steps the company has taken to address the issue on a July 24 quarterly earnings call.